Prism marketview: biotech in motion – lipella pharmaceuticals celebrates year of success

New york, december 20, 2023 – clinical-stage biotechnology company, lipella pharmaceuticals (nasdaq: lipo) is celebrating a year of strategic accomplishments on its first anniversary as a public company. lipella is advancing three clinical indications and has been granted two orphan drug designations by the us food and drug administration (fda).
LIPO Ratings Summary
LIPO Quant Ranking